StockNews.com assumed coverage on shares of Prime Medicine (NYSE:PRME – Get Rating) in a report published on Thursday morning. The firm issued a sell rating on the stock.
Prime Medicine Stock Performance
Prime Medicine stock opened at $12.29 on Thursday. The stock has a 50-day simple moving average of $17.06. Prime Medicine has a 52 week low of $12.29 and a 52 week high of $21.73.
Prime Medicine Company Profile
- Get a free copy of the StockNews.com research report on Prime Medicine (PRME)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Prime Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prime Medicine and related companies with MarketBeat.com's FREE daily email newsletter.